Oct 20, 2021 06:11 PM (GMT+8) · EqualOcean
Financial Associated Press, October 20 - Tiantan biology announced that its affiliated enterprises obtained the drug clinical trial approval issued by the United Arab Emirates and agreed to carry out the clinical trial of "intravenous covid-19 human immunoglobulin (pH4)" in Wuhan blood system.